Arterial Revascularisation Trial - a randomised trial to compare survival following bilateral versus single internal mammary artery (IMA) grafting in coronary revascularisation
Overview
- Phase
- 未知
- Status
- Active, not recruiting
- Sponsor
- niversity of Oxford (UK)
- Enrollment
- 3,102
Overview
Brief Summary
2006 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/16573820 protocol 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20805116 results 2011 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/21943128 assessment of data quality 2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25217501 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27112712 results 2016 Results article in https://www.ncbi.nlm.nih.gov/pubmed/27959712 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28566338 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28450552 results 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29502105 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30699314 results 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/30948516/ results (added 11/06/2020)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Coronary artery bypass graft (CABG) patients with multi\-vessel coronary artery disease (including urgent and off pump CABG patients)
Exclusion Criteria
- •1\. Single graft
- •2\. Redo CABG
- •3\. Evolving myocardial infarction
- •4\. Concomitant valve surgery